Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130(4):469–76.
Article CAS PubMed Google Scholar
Galor A, Thorne JE. Scleritis and peripheral ulcerative keratitis. Rheum Dis Clin North Am. 2007;33(4):835–54.
Article PubMed PubMed Central Google Scholar
Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology. 1991;98(4):467–71.
Article CAS PubMed Google Scholar
Braithwaite T, Adderley NJ, Subramanian A, Galloway J, Kempen JH, Gokhale K, et al. Epidemiology of scleritis in the United Kingdom from 1997 to 2018: population-based analysis of 11 million patients and association between scleritis and infectious and immune-mediated inflammatory disease. Arthritis Rheumatol. 2021;73(7):1267–76.
Thong LP, Rogers SL, Hart CT, Hall AJ, Lim LL. Epidemiology of episcleritis and scleritis in urban Australia. Clin Exp Ophthalmol. 2020;48(6):757–66.
Homayounfar G, Nardone N, Borkar DS, Tham VM, Porco TC, Enanoria WT, et al. Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study. Am J Ophthalmol. 2013;156(4):752–8.
Honik G, Wong IG, Gritz DC. Incidence and prevalence of episcleritis and scleritis in Northern California. Cornea. 2013;32(12):1562–6.
Armbrust KR, Kopplin LJ. Characteristics and outcomes of patients with scleritis in the IRIS® Registry (Intelligent Research in Sight) Database. Ophthalmol Sci. 2022;2(3): 100178.
Article PubMed PubMed Central Google Scholar
de-la-Torre A, Cabrera-Pérez M, Durán C, García S, Cuevas M, Carreño N, et al. Clinical patterns and risk factors in scleritis: a multicentric study in Colombia. Graefes Arch Clin Exp Ophthalmol. 2022;260(12):3957–67.
Xu TT, Reynolds MM, Hodge DO, Smith WM. Epidemiology and clinical characteristics of episcleritis and scleritis in Olmsted County, Minnesota. Am J Ophthalmol. 2020;217:317–24.
Article PubMed PubMed Central Google Scholar
Magesan K, Surya J, Sridharan S, Nair V, Agarwal M, Agarwal AE, et al. Clinical profile of scleritis presenting for the first time in the elderly. Ocul Immunol Inflamm. 2023;31(4):696–700.
Akpek EK, Thorne JE, Qazi FA, Do DV, Jabs DA. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111(3):501–6.
Lavric A, Gonzalez-Lopez JJ, Majumder PD, Bansal N, Biswas J, Pavesio C, et al. Posterior scleritis: analysis of epidemiology, clinical factors, and risk of recurrence in a cohort of 114 patients. Ocul Immunol Inflamm. 2016;24(1):6–15.
Murthy SI, Sabhapandit S, Balamurugan S, Subramaniam P, Sainz-de-la-Maza M, Agarwal M, et al. Scleritis: differentiating infectious from non-infectious entities. Indian J Ophthalmol. 2020;68(9):1818–28.
Article PubMed PubMed Central Google Scholar
Zhang Y, Amin S, Lung KI, Seabury S, Rao N, Toy BC. Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: a claims-based analysis. PLoS ONE. 2020;15(8): e0237995.
Article CAS PubMed PubMed Central Google Scholar
Fraunfelder FW, Fraunfelder FT. Adverse ocular drug reactions recently identified by the National Registry of drug-induced ocular side effects. Ophthalmology. 2004;111(7):1275–9.
Article CAS PubMed Google Scholar
Hemmati I, Wade J, Kelsall J. Risedronate-associated scleritis: a case report and review of the literature. Clin Rheumatol. 2012;31(9):1403–5.
Provost C, Sené T, Lecler A. Bisphosphonate-induced posterior scleritis. Ophthalmology. 2021;128(3):371.
Tabbara KF. Nodular scleritis following alendronate therapy. Ocul Immunol Inflamm. 2008;16(3):99–101.
Chartrand NA, Lau CK, Parsons MT, Handlon JJ, Ronquillo YC, Hoopes PC, et al. Ocular Side effects of bisphosphonates: a review of literature. J Ocul Pharmacol Ther. 2023;39(1):3–16.
Article CAS PubMed Google Scholar
Fraunfelder FW, Fraunfelder FT, Jensvold B. Scleritis and other ocular side effects associated with pamidronate disodium. Am J Ophthalmol. 2003;135(2):219–22.
Article CAS PubMed Google Scholar
Hashimoto Y, Yamana H, Iwagami M, Ono S, Takeuchi Y, Michihata N, et al. Ocular adverse events after coronavirus disease 2019 mRNA vaccination: matched cohort and self-controlled case series studies using a large database. Ophthalmology. 2023;130(3):256–64.
Sanjay S, Handa A, Kawali A, Shetty R, Bhakti Mishra S, Mahendradas P. Scleritis and episcleritis following coronavirus disease (COVID-19) vaccination. Ocul Immunol Inflamm. 2023;31(6):1184–90.
Article CAS PubMed Google Scholar
Akbari MR, Mohebbi M, Johari M, Mirmohammadsadeghi A, Mahmoudi A. Multifocal surgically induced necrotizing scleritis following strabismus surgery: a case report. Strabismus. 2016;24(3):101–5.
Pujari A, Chaniyara MH, Sharma P, Sharma N. Necrotizing scleritis following uncomplicated strabismus surgery. Indian J Ophthalmol. 2020;68(11):2555–7.
Article PubMed PubMed Central Google Scholar
Hong CM, Shin MH, Kim SJ, Seo SW, Chung I, Yoo WS. Bilateral posterior scleritis after sequential bilateral cataract surgery: a case report. BMC Ophthalmol. 2022;22(1):321.
Article PubMed PubMed Central Google Scholar
Matsuura K, Uotani R, Inoue Y. Bilateral diffuse anterior scleritis after unilateral cataract surgery: a case report. J Pak Med Assoc. 2021;71(3):1014–6.
Aktas Z, Bektas C, Hasanreisoglu M. Panscleritis as an unusual complication of gonioscopy-assisted transluminal trabeculotomy. J Glaucoma. 2019;28(2):e21–3.
Wong JC, Savsani E, Mahmoudzadeh R, Salabati M, Razeghinejad R, Lee D, et al. Glaucoma surgical outcomes in patients with a history of scleritis. Ocul Immunol Inflamm. 2023;21:1–7.
Roufas A, Jalaludin B, Gaskin C, McCluskey P. Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis. Br J Ophthalmol. 2010;94(6):743–7.
Article CAS PubMed Google Scholar
Fraunfelder FT, Watson PG. Evaluation of eyes enucleated for scleritis. Br J Ophthalmol. 1976;60(3):227–30.
Article CAS PubMed PubMed Central Google Scholar
Tu EY, Culbertson WW, Pflugfelder SC, Huang A, Chodosh JC. Therapy of nonnecrotizing anterior scleritis with subconjunctival corticosteroid injection. Ophthalmology. 1995;102(5):718–24.
Article CAS PubMed Google Scholar
Albini TA, Zamir E, Read RW, Smith RE, See RF, Rao NA. Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis. Ophthalmology. 2005;112(10):1814–20.
Zamir E, Read RW, Smith RE, Wang RC, Rao NA. A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis. Ophthalmology. 2002;109(4):798–805 (discussion 807).
Foster CS, Kothari S, Anesi SD, Vitale AT, Chu D, Metzinger JL, et al. The ocular immunology and uveitis foundation preferred practice patterns of uveitis management. Surv Ophthalmol. 2016;61(1):1–17.
Davis A, Robson R. The dangers of NSAIDs: look both ways. Br J Gen Pract. 2016;66(645):172–3.
Article PubMed PubMed Central Google Scholar
Abdulla A, Adams N, Bone M, Elliott AM, Gaffin J, Jones D, et al. Guidance on the management of pain in older people. Age Ageing. 2013;42(Suppl. 1):i1–57.
Cameron C. Non-steroidal anti-inflammatory drugs: making better treatment choices. Best Pract J. 2013;55:9–18.
Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Scleritis therapy. Ophthalmology. 2012;119(1):51–8.
Bauer AM, Fiehn C, Becker MD. Celecoxib, a selective inhibitor of cyclooxygenase 2 for therapy of diffuse anterior scleritis. Am J Ophthalmol. 2005;139(6):1086–9.
留言 (0)